Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3584903efe1babebbd056e855a2cc2b3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-08 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
filingDate |
2018-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ce6ba7b8d1813842dacf55ffd56a220 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d16c30ac198218a422a72378b2b2890e |
publicationDate |
2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20190139119-A |
titleOfInvention |
Monoclonal antibody against marine birnavirus and nervous necrosis virus, and use thereof |
abstract |
The present invention relates to a monoclonal antibody specific to marine Bernavirus (MABV) and its use, and more particularly marine Bernavirus and neuronecrosis virus having excellent sensitivity and specificity by using the marine Bernavirus (MABV) structural protein as an epitope (Nervous Necrosis Virus, NNV) The present invention relates to a monoclonal antibody specific for marine vernavirus and neuronecrosis virus which can be usefully used for the diagnosis, prevention and treatment of infection, and its use. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220005363-A |
priorityDate |
2018-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |